Log In
BCIQ
Print this Print this
 

TP-3654

  Manage Alerts
Collapse Summary General Information
Company Tolero Pharmaceuticals Inc.
DescriptionSmall molecule pan-Pim (PIM) kinase inhibitor
Molecular Target Pim-1 (PIM1) ; Pim-2 (PIM2)
Mechanism of ActionPIM1 inhibitor; PIM2 inhibitor; PIM3 inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$780.0M

$200.0M

$580.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/21/2016

$780.0M

$200.0M

$580.0M

Get a free BioCentury trial today